衰弱进展与心血管结局:Medicare受益者研究
校正年龄和基线衰弱指数后,衰弱进展者MACCE、全因死亡、心衰加重、缺血性卒中和心肌梗死风险均显著升高,且进展越快风险越高、居家存活天数越少。
要点
- 衰弱进展独立于年龄和基线衰弱,与MACCE及全因死亡风险升高相关。
- 衰弱进展越快,MACCE、死亡、心衰、卒中和心梗风险呈梯度增加。
- 衰弱进展者居家存活天数显著少于衰弱消退者。
核心结论
- 在大型全国性老年Medicare受益者样本中,衰弱进展独立于年龄和基线衰弱,与更少居家存活天数及MACCE、全因死亡、心肌梗死、心衰加重和缺血性卒中的梯度风险相关。
研究设计与样本
- 研究评估2003至2015年连续入组的≥65岁Medicare按服务收费受益人,采用线性混合效应模型估计5年内基于索赔的衰弱指数(CFI)变化,并用生存分析检验衰弱进展与不良健康结局风险。
主要发现
- 中位随访2.4年期间,60%患者衰弱进展,40%衰弱消退。
- 校正年龄和基线CFI后,衰弱进展者较消退者MACCE风险HR 1.31(95%CI 1.31-1.31),全因死亡HR 1.34(95%CI 1.34-1.34)。
- 衰弱进展者急性心肌梗死HR 1.08(95%CI 1.07-1.09),心衰加重HR 1.30(95%CI 1.29-1.30),缺血性卒中HR 1.14(95%CI 1.14-1.15)。
- 进展越快,各结局风险梯度增加;最快进展组居家存活天数270.4±112.3天,慢进展组308.6±93.0天,率比0.88(95%CI 0.87-0.88,p<0.001)。
关键数值与推荐
- 衰弱进展定义为5年期间CFI变化;校正年龄和基线CFI后比较进展与消退者的结局风险。
- MACCE风险HR 1.31(95%CI 1.31-1.31),全因死亡HR 1.34(95%CI 1.34-1.34)。
- 急性心肌梗死HR 1.08(95%CI 1.07-1.09),心衰加重HR 1.30(95%CI 1.29-1.30),缺血性卒中HR 1.14(95%CI 1.14-1.15)。
- 居家存活天数最快进展组270.4±112.3天 vs. 最慢进展组308.6±93.0天,率比0.88(95%CI 0.87-0.88,p<0.001)。
临床怎么用
- 对老年患者应动态评估衰弱变化,不仅关注基线衰弱状态。
- 衰弱进展较快者需加强心血管事件和死亡风险的监测与综合管理。
- 可将延缓衰弱进展作为改善居家存活和心血管预后的潜在干预目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty is associated with adverse cardiovascular outcomes independent of age and comorbidities, yet the independent influence of frailty progression on cardiovascular outcomes remains uncertain. METHODS: To determine whether frailty progression is associated with adverse cardiovascular outcomes, independent of baseline frailty and age, we evaluated all Medicare Fee-for-Service beneficiaries ≥65 years at cohort inception with continuous enrollment from 2003 to 2015. Linear mixed effects models, adjusted for baseline frailty and age, were used to estimate change in a validated claims-based frailty index (CFI) over a 5-year period. Survival analysis was used to examine frailty progression and risk of adverse health outcomes. RESULTS: There were 8.9 million unique patients identified, mean age 77.3 ± 7.2 years, 58.7% female, 10.9% non-White race. In total, 60% had frailty progression and 40% frailty regression over median follow-up of 2.4 years. Compared to those with frailty regression, when adjusting for age and baseline CFI, those with frailty progression had a significantly greater risk of incident major adverse cardiovascular and cerebrovascular events (MACCE) (hazard ratio [HR] 1.31, 95% confidence interval [CI] 1.31-1.31), all-cause mortality (HR 1.34, 95% CI 1.34-1.34), acute myocardial infarction (HR 1.08, 95% CI 1.07-1.09), heart failure exacerbation (HR 1.30, 95% CI 1.29-1.30), ischemic stroke (HR 1.14, 95% CI 1.14-1.15). There was also a graded increase in risk of each outcome with more rapid progression, as well as significantly fewer days alive at home (DAH) with more rapid progression compared to the slowest progression group (270.4 ± 112.3 vs. 308.6 ± 93.0 days, rate ratio 0.88, 95% CI 0.87-0.88, p < 0.001). CONCLUSIONS: In this large, nationwide sample of older Medicare beneficiaries, frailty progression, independent of age and baseline frailty, was associated with fewer DAH and a graded risk of MACCE, all-cause mortality, myocardial infarction, heart failure, and ischemic stroke compared to those with frailty regression.
引用
- Gong Y, Song Y, Xu J, et al. Progression of frailty and cardiovascular outcomes among Medicare beneficiaries. J Am Geriatr Soc. 2024. PMID: 39091085. doi:10.1111/jgs.19116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。